Latest Insider Transactions at Tarsus Pharmaceuticals, Inc. (TARS)
This section provides a real-time view of insider transactions for Tarsus Pharmaceuticals, Inc. (TARS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Tarsus Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Tarsus Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Leonard M. Greenstein Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,462
+10.33%
|
-
|
|
Mar 15
2023
|
Bobak R. Azamian President/CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
11,299
+46.41%
|
-
|
|
Mar 15
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.73%
|
$104,000
$13.79 P/Share
|
|
Mar 09
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
717
-0.07%
|
$10,755
$15.01 P/Share
|
|
Mar 08
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
4,853
-0.44%
|
$72,795
$15.02 P/Share
|
|
Feb 16
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-12.73%
|
$75,000
$15.12 P/Share
|
|
Feb 15
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.73%
|
$120,000
$15.28 P/Share
|
|
Feb 08
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.81%
|
$135,000
$15.14 P/Share
|
|
Jan 23
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
4,856
-0.44%
|
$72,840
$15.45 P/Share
|
|
Jan 20
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
240
-0.02%
|
$3,600
$15.0 P/Share
|
|
Jan 19
2023
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-11.29%
|
$70,000
$14.56 P/Share
|
|
Jan 18
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.71%
|
$112,000
$14.56 P/Share
|
|
Jan 11
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
3,904
-0.35%
|
$58,560
$15.11 P/Share
|
|
Jan 10
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
905
-0.08%
|
$13,575
$15.17 P/Share
|
|
Jan 09
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
729
-0.06%
|
$10,935
$15.15 P/Share
|
|
Jan 06
2023
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
411
-0.04%
|
$6,165
$15.0 P/Share
|
|
Dec 21
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.7%
|
$112,000
$14.57 P/Share
|
|
Dec 16
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
535
-0.05%
|
$8,025
$15.01 P/Share
|
|
Dec 15
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-10.14%
|
$70,000
$14.64 P/Share
|
|
Dec 14
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
6,420
-0.56%
|
$96,300
$15.08 P/Share
|
|
Dec 02
2022
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
1,154
-7.76%
|
$18,464
$16.9 P/Share
|
|
Dec 02
2022
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,154
-11.68%
|
$18,464
$16.9 P/Share
|
|
Dec 01
2022
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,165
-10.55%
|
$18,640
$16.75 P/Share
|
|
Dec 01
2022
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
1,164
-7.26%
|
$18,624
$16.75 P/Share
|
|
Nov 30
2022
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
1,182
-9.67%
|
$18,912
$16.5 P/Share
|
|
Nov 30
2022
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
1,183
-6.87%
|
$18,928
$16.5 P/Share
|
|
Nov 29
2022
|
Dianne C. Whitfield Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,251
+45.61%
|
-
|
|
Nov 29
2022
|
Bryan Wahl General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,251
+37.31%
|
-
|
|
Nov 17
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.21%
|
$80,000
$16.54 P/Share
|
|
Nov 16
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.35%
|
$136,000
$17.06 P/Share
|
|
Nov 15
2022
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,857
-12.12%
|
$116,569
$17.72 P/Share
|
|
Nov 10
2022
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
8,382
+33.72%
|
-
|
|
Nov 10
2022
|
William J Phd Link Director |
SELL
Other acquisition or disposition
|
Indirect |
215,575
-33.33%
|
-
|
|
Nov 09
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.77%
|
$153,000
$17.87 P/Share
|
|
Oct 20
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-4.23%
|
$80,000
$16.26 P/Share
|
|
Oct 19
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.34%
|
$136,000
$17.26 P/Share
|
|
Oct 12
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.38%
|
$144,000
$16.0 P/Share
|
|
Sep 21
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.34%
|
$128,000
$16.67 P/Share
|
|
Sep 15
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.78%
|
$80,000
$16.03 P/Share
|
|
Sep 14
2022
|
Elizabeth Yeu Lin Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
18,400
+50.0%
|
$294,400
$16.16 P/Share
|
|
Sep 14
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
9,000
-0.75%
|
$144,000
$16.01 P/Share
|
|
Aug 24
2022
|
Aziz Mottiwala Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,188
+4.34%
|
$25,940
$5.72 P/Share
|
|
Aug 18
2022
|
Leonard M. Greenstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-7.22%
|
$80,000
$16.3 P/Share
|
|
Aug 17
2022
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Indirect |
8,000
-0.33%
|
$128,000
$16.97 P/Share
|
|
Aug 15
2022
|
William J Phd Link Director |
BUY
Other acquisition or disposition
|
Indirect |
3,749
+31.65%
|
-
|
|
Aug 15
2022
|
William J Phd Link Director |
SELL
Other acquisition or disposition
|
Indirect |
215,575
-25.0%
|
-
|
|
Jun 15
2022
|
Michael Ackermann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,257
+0.35%
|
-
|
|
May 05
2022
|
Michael Ackermann Director |
BUY
Open market or private purchase
|
Indirect |
100,000
+50.0%
|
$1,300,000
$13.5 P/Share
|
|
May 05
2022
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,374
-0.22%
|
$64,488
$12.25 P/Share
|
|
May 04
2022
|
Vivo Capital Ix, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,738
-0.79%
|
$236,856
$12.67 P/Share
|